Exposing GSK’s Unlawful Practices: A $3 Billion Whistleblowing Case Study

GlaxoSmithKline  Case Study: Unveiling GSK’s Wrongdoings Costing the Company a $3 Billion Settlement    GlaxoSmithKline, a major pharmaceutical player, had been under investigation for unlawful practices. Allegations included misleading drug promotion, failure to report safety data, and false price reporting. This initiated a comprehensive investigation, culminating in a legal battle to expose GSK’s misconduct and […]